Viewing Study NCT01509560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2026-05-17 @ 12:44 PM
Study NCT ID: NCT01509560
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2012-01-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood
Sponsor: Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Condition After Allogenic Peripheral Stem Cell Transplantation (SCT) View
Keywords: